Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020943
Company: SOCIETAL CDMO
Company: SOCIETAL CDMO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
VERELAN PM | VERAPAMIL HYDROCHLORIDE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
VERELAN PM | VERAPAMIL HYDROCHLORIDE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription | None | Yes | No |
VERELAN PM | VERAPAMIL HYDROCHLORIDE | 300MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/25/1998 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20943lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20943ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20-943_VerelanPM.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
10/03/2019 | SUPPL-35 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020943Orig1s035ltr.pdf | |
11/18/2016 | SUPPL-32 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020943s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020943Orig1s032ltr.pdf | |
10/14/2014 | SUPPL-29 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020943s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020943Orig1s029ltr.pdf | |
11/14/2011 | SUPPL-28 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020943s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020943s028ltr.pdf | |
04/01/2010 | SUPPL-26 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020943s007s026.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020943s007s026ltr.pdf | |
12/16/2009 | SUPPL-21 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020943s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020943s021ltr.pdf | |
05/01/2007 | SUPPL-20 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020943s020ltr.pdf |
05/05/2004 | SUPPL-13 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20943slr013_verapamil_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20943slr013ltr.pdf | |
12/26/2002 | SUPPL-9 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
04/01/2010 | SUPPL-7 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020943s007s026.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020943s007s026ltr.pdf | |
11/29/2000 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
07/27/2000 | SUPPL-4 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/13/1999 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/04/1999 | SUPPL-2 | Labeling |
Label is not available on this site. |
||
07/02/1999 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
10/03/2019 | SUPPL-35 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf | |
11/18/2016 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020943s032lbl.pdf | |
10/14/2014 | SUPPL-29 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020943s029lbl.pdf | |
11/14/2011 | SUPPL-28 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020943s028lbl.pdf | |
04/01/2010 | SUPPL-26 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020943s007s026.pdf | |
04/01/2010 | SUPPL-7 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020943s007s026.pdf | |
12/16/2009 | SUPPL-21 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020943s021lbl.pdf | |
05/05/2004 | SUPPL-13 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20943slr013_verapamil_lbl.pdf | |
11/25/1998 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20943lbl.pdf |